CannRx Pain Control Formulation

CannRx Pain Control Formulation is a preclinical **cannabis-based pain management formulation** developed by CannRx Technology. It uses the company's proprietary **CannTrap** nanoparticle delivery platform to solubilize cannabis-derived cannabinoids and terpenes into water-soluble nanoparticles designed to bind circulating proteins in the bloodstream, with the goal of improving delivery and enabling rapid onset of analgesic effect. Publicly available company materials describe extensive in vivo testing and report significant, rapid pain relief, but do not disclose a precise active composition, individual cannabinoid ratios, molecular targets, dosage form, route of administration, or any later-stage clinical development updates.

Other names

CannRx Pain Control Formulation